AGN Price sensitive 3 Sep 2025, 9:34 AM

Topline Phase 2 Trial Results of ARG-007 in AIS Patients

Argenica Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in